RETNLB ELISA Kit

Catalog No. ABIN4219263

Product Details RETNLB ELISA Kit

Target: RETNLB (Resistin Like beta (RETNLB))

Reactivity: Human

Detection Method: Colorimetric

Method Type: Sandwich ELISA

Detection Range: 0.016-1 ng/mL

Minimum Detection Limit: 0.016 ng/mL

Application: ELISA

Analytical Method: Quantitative

Cross-Reactivity: Human

Sensitivity: 10 pg/mL

Characteristics: RELM-beta (human) Matched Pair Detection Set

Components: 1 vial standard protein (1μg) (lyophilized) [STD] 1 vial coating antibody (300μl) [COAT] 1 vial detection antibody (120μl) [DET] 1 vial anti-rabbit IgG-HRP (8μg) (lyophilized) [HRP]

Application Details

Plate: Without plate

Restrictions: For Research Use only

Handling

Storage: 4 °C,-20 °C

Storage Comment: Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at +4°C.

Expiry Date: 6 months

Target Details for RETNLB

Target: RETNLB (Resistin Like beta (RETNLB))

Alternative Name: RELM-beta (RETNLB Products)

Synonyms: FIZZ1 ELISA Kit, FIZZ2 ELISA Kit, HXCP2 ELISA Kit, RELM-beta ELISA Kit, RELMb ELISA Kit, RELMbeta ELISA Kit, XCP2 ELISA Kit, RETNLB ELISA Kit, 9030012B21Rik ELISA Kit, Fizz2 ELISA Kit, Relmb ELISA Kit, Xcp3 ELISA Kit, resistin like beta ELISA Kit, RETNLB ELISA Kit, Retnlb ELISA Kit

Background: RELM-beta is a 19 kDa disulfide-linked homodimeric protein expressed in the epithelium of the colon and small bowel. RELM-beta has been suggested to play a regulatory role during inflammation and may also act to establish links among adipose tissue, the intestine and the liver. Interestingly, the molecular structure of RELM-beta is highly homologous to that of the adipose-derived cytokine resistin. The specific and sensitive RELM-beta Matched Pair Detection Set might detect RELM-beta in serum of gut-inflamed patients (e. g. inflammatory bowel diseases, Crohn disease and ulcerative colitis). Natural levels of RELM-beta were seen in stool, but were not detectable in the serum or other cell culture models of healthy human patients. Further testing are ongoing.

UniProt: Q2UXL7

Pathways: Hormone Activity